Over-expression of platelet-derived growth factor in human diabetic nephropathy.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Nephrology, Dialysis and Transplantation

• Publication date

  2003-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/NDT/GFG177PMID 12808179
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Platelet-derived growth factor-D expression in developing and mature human kidneys.

  2002cited by this paper
• Immunohistochemical characterization of glomerular PDGF B-chain and PDGF beta-receptor expression in diabetic rats.

  2000cited by this paper
• Aminoguanidine ameliorates overexpression of prosclerotic growth factors and collagen deposition in experimental diabetic nephropathy.

  2000cited by this paper
• Urinary excretion of TGF-beta 1, PDGF-BB and fibronectin in insulin-dependent diabetes mellitus patients.

  1997cited by this paper
• Altered expression of fibrogenic growth factors in IgA nephropathy and focal and segmental glomerulosclerosis.

  1997cited by this paper
• Application of Photoshop-based Image Analysis to Quantification of Hormone Receptor Expression in Breast Cancer

  1997cited by this paper
• Increased production of PDGF by angiotensin and high glucose in human vascular endothelium.

  1996cited by this paper
• Improved purification and yields of RNA by RNeasy.

  1996cited by this paper
• Platelet-derived growth factor A-chain expression in developing and mature human kidneys and in Wilms' tumor.

  1995cited by this paper
• Stable expression of human platelet-derived growth factor B chain by bovine aortic endothelial cells. Matrix association and selective proteolytic cleavage by thrombin.

  1994cited by this paper
• Expression of cytokines and growth factors in human glomerulonephritides

  1993cited by this paper
• Infusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial cell proliferation and matrix accumulation in rats.

  1993cited by this paper
• Renal injury from angiotensin II-mediated hypertension.

  1992cited by this paper
• Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor.

  1992cited by this paper
• Platelet-derived growth factor expression in mesangial proliferative glomerulonephritis.

  1991cited by this paper
• Platelet-derived growth factor: mechanism of action and possible in vivo function.

  1990cited by this paper
• Sera and conditioned media contain different isoforms of platelet-derived growth factor (PDGF) which bind to different classes of PDGF receptor.

  1989cited by this paper
• Quantitation of mRNA by the polymerase chain reaction.

  1989cited by this paper
• Could platelet-derived growth factor have a role in the pathogenesis of lupus nephritis?

  1988cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• The biology of platelet-derived growth factor

  1986cited by this paper
• J Am Soc Nephrol 13: 910–917, 2002 Expression of a Novel PDGF Isoform, PDGF-C, in Normal and Diseased Rat Kidney

  year unknowncited by this paper

• Renal microcirculation and mechanisms in diabetic kidney disease

  2025cites this paper
• The causal association between cardiovascular proteins and diabetic nephropathy: a Mendelian randomization study

  2025cites this paper
• High glucose couples DJ-1 with PTEN to activate PDGFRβ for renal proximal tubular cell injury

  2025cites this paper
• Curcumin prevents high glucose-induced stimulatory effects of renal cell secretome on fibroblast activation via mitigating intracellular free radicals and TGF-β secretion.

  2024cites this paper
• Research progress on the role of PDGF/PDGFR in type 2 diabetes.

  2023cites this paper
• TRAIL and EGFR Pathways Targeting MicroRNAs are Predominantly Regulated in Human Diabetic Nephropathy.

  2023cites this paper
• Dysregulated coagulation system links to inflammation in diabetic kidney disease

  2023cites this paper
• Modified lipid metabolism and cytosolic phospholipase A2 activation in mesangial cells under pro-inflammatory conditions

  2022cites this paper
• Cellular crosstalk of glomerular endothelial cells and podocytes in diabetic kidney disease

  2022cites this paper
• The Role of Platelets in Diabetic Kidney Disease

  2022cites this paper
• Therapeutic Approaches Targeting Molecular Signaling Pathways Common to Diabetes and Lung Diseases and Cancer.

  2021cites this paper
• Diabetic fibrosis.

  2020cites this paper
• Pericyte Bridges in Homeostasis and Hyperglycemia

  2020cites this paper
• TGFβ acts through PDGFRβ to activate mTORC1 via the Akt/PRAS40 axis and causes glomerular mesangial cell hypertrophy and matrix protein expression

  2020cites this paper
• Role of platelet-derived growth factor in type II diabetes mellitus and its complications

  2020cites this paper
• Inhibition of core fucosylation limits progression of diabetic kidney disease.

  2019cites this paper
• Pericyte Bridges in Homeostasis and Hyperglycemia: Reconsidering Pericyte Dropout and Microvascular Structures

  2019cites this paper
• Title Conditional Deletion of Smad 1 Ameliorates Glomerular Injuryin Progressive Glomerulonephritis

  2018cites this paper
• Tyrosines-740/751 of PDGFRβ contribute to the activation of Akt/Hif1α/TGFβ nexus to drive high glucose-induced glomerular mesangial cell hypertrophy.

  2018cites this paper
• PDGF receptor-β uses Akt/mTORC1 signaling node to promote high glucose-induced renal proximal tubular cell collagen I (α2) expression.

  2017cites this paper
• Sitagliptin reduces transforming growth factor-β1 and Platelet derived growth factor-BB in regulation of UAER in type 2 diabetic nephropathy stage III patients

  2017influential citation
• TYROSINE KINASE INHIBITION IN EXPERIMENTAL KIDNEY TRANSPLANTATION

  2017cites this paper
• Bone Morphogenic Protein 4-Smad–Induced Upregulation of Platelet-Derived Growth Factor AA Impairs Endothelial Function

  2016cites this paper
• Mesenchymal stem cells: a future experimental exploration for recession of diabetic nephropathy

  2016cites this paper
• Conditional Deletion of Smad1 Ameliorates Glomerular Injury in Progressive Glomerulonephritis

  2016cites this paper
• A Systems Biology Overview on Human Diabetic Nephropathy: From Genetic Susceptibility to Post-Transcriptional and Post-Translational Modifications

  2015cites this paper
• Characterization of binding mode of action of a blocking anti-platelet-derived growth factor (PDGF)-B monoclonal antibody, MOR8457, reveals conformational flexibility and avidity needed for PDGF-BB to bind PDGF receptor-β.

  2015cites this paper
• The Ca2+/calmodulin-dependent protein kinase IIα (Thr286Asp) transgenic mice: a novel mouse model of severe insulin-dependent diabetes

  2014cites this paper
• Hyperglycemia to nephropathy via transforming growth factor beta.

  2014cites this paper
• Root of Polygonum cuspidatum extract reduces progression of diabetes-induced mesangial cell dysfunction via inhibition of platelet-derived growth factor-BB (PDGF-BB) and interaction with its receptor in streptozotocin-induced diabetic rats

  2014cites this paper
• Gene expression in peripheral blood of patients with hypertension and patients with type 2 diabetes

  2014cites this paper
• GLUT1 Regulation of the Pro-Sclerotic Mediators of Diabetic Nephropathy

  2013cites this paper
• Pathophysiology and Complications of Diabetes Mellitus

  2012cites this paper
• Antioxidant Therapy for Diabetic Kidney Disease

  2012cites this paper
• Urinary Platelet-Derived Growth Factor-BB as an Early Marker of Nephropathy in Patients with Type 2 Diabetes: An Egyptian Study

  2012influential citation
• Endothelial dysfunction as a risk factor for cardiovascular disease; its modulation by phyto-ingredients and implication in better cardiovascular health. -

  2012cites this paper
• T-type calcium channels and human mesangial cell proliferation

  2012cites this paper
• Deletion of platelet-derived growth factor receptor-β improves diabetic nephropathy in Ca2+/calmodulin-dependent protein kinase IIα (Thr286Asp) transgenic mice

  2011cites this paper
• Pathophysiology of the diabetic kidney.

  2011cites this paper
• The changes of platelet-derived growth factor-BB (PDGF-BB) in T2DM and its clinical significance for early diagnosis of diabetic nephropathy.

  2009cites this paper
• Lack of Type VIII Collagen in Mice Ameliorates Diabetic Nephropathy

  2009cites this paper
• Role of Growth Factors in Diabetic Kidney Disease

  2009cites this paper
• Macrophage infiltration into adipose tissue may promote angiogenesis for adipose tissue remodeling in obesity.

  2008cites this paper
• Effect of Panaxnotoginseng on the Platelet-derived Growth Factor-BB and Its mRNA's Expression on Adriamycin-induced-nephropathy Rats

  2008cites this paper
• Agents in development for the treatment of diabetic nephropathy

  2008cites this paper
• Lipoxins: update and impact of endogenous pro-resolution lipid mediators.

  2008cites this paper
• NOVEL INSIGHTS IN THE TREATMENT OF DIABETIC NEPHROPATHY

  2007cites this paper
• ACE inhibitor reduces growth factor receptor expression and signaling but also albuminuria through B2-kinin glomerular receptor activation in diabetic rats.

  2007cites this paper
• Growth factors in diabetic complications

  2006cites this paper
• Transforming growth factor-beta-regulated gene transcription and protein expression in human GFAP-negative lamina cribrosa cells.

  2005cites this paper
• Blocking platelet-derived growth factor-D/platelet-derived growth factor receptor beta signaling inhibits human renal cell carcinoma progression in an orthotopic mouse model.

  2005cites this paper
• Imatinib attenuates diabetic nephropathy in apolipoprotein E-knockout mice.

  2005cites this paper
• Matrix metalloproteinase-2 contributes to cancer cell migration on collagen.

  2005cites this paper
• Regulation of PDGF and its receptors in fibrotic diseases.

  2004cites this paper
• From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines.

  2004influential citation
• Macrophages in streptozotocin-induced diabetic nephropathy: potential role in renal fibrosis.

  2004cites this paper
• Gene expression in diabetic nephropathy

  2004cites this paper
• Expression of two alternative transcription forms of platelet-derived growth factor-A chain in the normal human kidney and in glomerulonephritis.

  2004cites this paper
• Increased expression of urotensin II and urotensin II receptor in human diabetic nephropathy.

  2004cites this paper
• Current literature in diabetes

  2003cites this paper
• Roles of PDGF in animal development

  2003cites this paper